Alessandro Schipani - Concepedia

Concepedia

Author

Alessandro Schipani

University of Liverpool

Also Known As

A Schipani, A. Schipani, Alessandro Schipani

27

Publications

1.2K

Citations

15

H-Index

32

Concepts

All Affiliations

University of Liverpool Liverpool School of Tropical Medicine University of Dundee Swiss Tropical and Public Health Institute Ospedale Amedeo di Savoia

AS

About

Alessandro Schipani is an author at University of Liverpool specializing in pharmacology, medicine, and public health.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	778
2	Natural Sciences	2	2	683
3	Public Health	2	2	95
4	Biochemistry	2	2	683
5	Chemical Biology	1	1	21

Alessandro Schipani

×

15

Publications

1.2K

Citations

15

H-Index

	Year	Citations
Lessons Learnt from Assembling Screening Libraries for Drug Discovery for Neglected Diseases Ruth Brenk, Alessandro Schipani, Daniel James, ChemMedChem Bioorganic ChemistryHit IdentificationAvailable Compounds 222Kinase InhibitorsLead Identification	2007	662
Antiretroviral Solid Drug Nanoparticles with Enhanced Oral Bioavailability: Production, Characterization, and In Vitro–In Vivo Correlation Tom O. McDonald, Marco Giardiello, Philip Martin, Advanced Healthcare Materials	2013	89
Population Pharmacokinetic Modeling of the Association between 63396C→T Pregnane X Receptor Polymorphism and Unboosted Atazanavir Clearance Alessandro Schipani, Marco Siccardi, Antonio D’Avolio, Antimicrobial Agents and Chemotherapy Genetic EpidemiologyHuman PolymorphismPharmacotherapyPhysiologically-based Pharmacokinetic ModelingPharmacodynamic Modeling	2010	71
Acyclic Nucleoside Analogues as Inhibitors of<i>Plasmodium</i><i>f</i><i>alciparum</i>dUTPase Corinne Nguyen, G.F. Ruda, Alessandro Schipani, Journal of Medicinal Chemistry	2006	57
Integration of population pharmacokinetics and pharmacogenetics: an aid to optimal nevirapine dose selection in HIV-infected individuals Alessandro Schipani, Christoph Wyen, Tabitha Mahungu, Journal of Antimicrobial Chemotherapy	2011	50
Pharmacokinetic and Pharmacodynamic Analysis of Efavirenz Dose Reduction Using an In Vitro–In Vivo Extrapolation Model Marco Siccardi, Lisa M. Almond, Alessandro Schipani, Clinical Pharmacology & Therapeutics	2012	48
Genetic Determinants of the Pharmacokinetic Variability of Rifampin in Malawian Adults with Pulmonary Tuberculosis Derek J. Sloan, Andrew D. McCallum, Alessandro Schipani, Antimicrobial Agents and Chemotherapy	2017	37
Design, Synthesis, and Evaluation of 5′‐Diphenyl Nucleoside Analogues as Inhibitors of the <i>Plasmodium falciparum</i> dUTPase Shahienaz E. Hampton, Beatriz Baragaña, Alessandro Schipani, ChemMedChem	2011	31
Estimation of the Effect of <i>Slco1B1</i> Polymorphisms on Lopinavir Plasma Concentration in HIV-Infected Adults Alessandro Schipani, Deirdre Egan, Laura Dickinson, Antiviral Therapy	2012	28
A simultaneous population pharmacokinetic analysis of rifampicin in Malawian adults and children Alessandro Schipani, Henry Pertinez, Rachel Mlota, British Journal of Clinical Pharmacology	2015	28

Page 1